Skip to main content
Premium Trial:

Request an Annual Quote

Sponsored
By MGI

Whole-Genome Sequencing Facilitates CRISPR-Cas12f1 System Upgrade

Researchers at the Korean Institute of Life Sciences and Technology used MGI's DNBSEQ-T7 sequencer, among other tools, to engineer an efficient, miniaturized CRISPR-Cas gene-editing system that may be more easily packed into vectors for clinical applications.

By Olink

Proteomics Can Complement Genomics to Identify New Regulatory Pathways, Biomarkers, and Drug Targets, According to Expert Panel

Experts say proteogenomic findings can provide provide prognostic biomarkers and robust targets for drug development.

By NanoString

Spatial Genomics Summit Provides Sneak Peek of New Spatial Molecular Imaging Platform

Talks at NanoString's fourth annual Spatial Genomics Summit shared early results from the CosMx Spatial Molecular Imager (SMI), which is slated for commercial rollout in the second half of 2022.

By Biognosys

Next-Generation Proteomics Delivers Insights Across the Oncology Pipeline: Highlights from the AACR 2022 Annual Meeting

Advances in proteomics are improving cancer biomarker discovery, drug discovery, and drug target validation.

By MolGen

Routine, Rather Than Incidental, COVID-19 Testing May be Key to Keeping Society Open

The symptom-based testing paradigm misses asymptomatic cases and transmission among undertested groups.

By SomaLogic

Proteomic Profiling to Aid in Rare Disease Research

Research published within the past three years highlights a unique role for proteomics to aid critical areas of unmet need in rare disease populations.

By Biognosys

Mass Spectrometry is Fueling Advancements in Plasma Proteomics for Biomarker Discovery

Plasma and serum are brimming with potential protein biomarkers that can provide detailed information about health and disease mechanisms without the need for invasive medical procedures.

By F. Hoffmann-La Roche Ltd.

Perspective: Embracing Personalized Healthcare Across the Cancer Care Continuum

Talks and presentations at the virtual ESMO congress demonstrate that the field of cancer research is heading into a new era of tailored treatments. 

By Illumina

Epigenetic Signatures May Indicate COVID-19 Infection and Predict Disease Severity

Disease classifiers based on DNA methylation patterns offer the potential to predict clinical outcomes across infectious diseases.

By Olink

Novel Proteomics Study Finds Potential Biomarkers for Risk and Treatment Response in Diabetes

A high-throughput platform for proteomic profiling with next-generation sequencing (NGS) readout identified early biomarkers for type 2 diabetes and predicted who will best respond to therapeutic intervention.